V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330009818 | 330003840 | 0 | 54.2 | Curative (C) | 2014-06-07 | 2014-07-16 | METHOTREXATE | null | N | 330007542 | METHOTREXATE |
| 330009819 | 330003846 | 1.68 | 33 | Curative (C) | 2015-08-12 | 2015-10-15 | Cisplatin 7 day | N | N | 330007560 | CISPLATIN |
| 330009820 | 330008082 | 1.73 | 75.5 | Disease modification (D) | null | 2015-01-27 | METHOTREXATE | N | null | 330007561 | METHOTREXATE |
| 330009821 | 330003848 | 1.69 | null | Curative (C) | 2014-02-14 | 2014-08-21 | METHOTREXATE | N | N | 330007562 | METHOTREXATE |
| 330009822 | 330003849 | 1.72 | 11.5 | Curative (C) | null | 2017-02-21 | DOXORUBICIN | null | null | 330007563 | DOXORUBICIN |
| 330009823 | 330003850 | 0 | 11.2 | Curative (C) | 2014-04-19 | 2014-04-24 | MIFAMURTIDE | 02 | N | 330007570 | MIFAMURTIDE |
| 330009824 | 330003851 | 1.76 | 69 | Neo-adjuvant (N) | 2017-07-05 | 2017-07-06 | DOXORUBICIN | N | N | 330007579 | DOXORUBICIN |
| 330009825 | 330003854 | 0 | 83 | Palliative (P) | 2014-01-13 | 2014-01-13 | Cisplatin | 02 | Y | 330007583 | CISPLATIN |
| 330009826 | 330003855 | 1.81 | 67.6 | null | null | 2017-03-02 | DOXORUBICIN | N | null | 330007585 | DOXORUBICIN |
| 330009827 | 330003856 | 0 | 83 | Adjuvant (A) | null | 2012-10-11 | MIFAMURTIDE | null | null | 330007587 | MIFAMURTIDE |
| 330009828 | 330003860 | 1.72 | null | Neo-adjuvant (N) | 2014-11-12 | 2014-11-12 | DOXORUBICIN | 2 | N | 330007588 | DOXORUBICIN |
| 330009829 | 330003862 | 1.77 | 53 | Palliative (P) | 2014-02-07 | 2014-08-05 | DOXORUBICIN | N | N | 330007591 | DOXORUBICIN |
| 330009830 | 330003862 | 0 | 66.6 | Curative (C) | 2014-12-15 | 2018-05-06 | OST Euramos 1 Closed Trial - A | 2 | N | 330007591 | DOXORUBICIN |
| 330009831 | 330008092 | 1.73 | 73.3 | Palliative (P) | 2017-04-23 | 2017-05-21 | Trial Unspecified | null | null | 330007601 | TRIAL |
| 330009835 | 330010389 | 1.81 | 82.6 | Curative (C) | 2016-01-18 | 2016-06-13 | Mifamurtide weeks 13-36 | 2 | N | 330007616 | MIFAMURTIDE |
| 330009836 | 330008098 | 1.83 | 53.3 | Adjuvant (A) | 2015-07-16 | 2015-07-16 | Cisplatin | N | Y | 330007623 | CISPLATIN |
| 330009837 | 330003874 | 1.8 | 31 | Curative (C) | 2016-03-13 | 2016-03-20 | MIFAMURTIDE | 02 | N | 330007628 | MIFAMURTIDE |
| 330009838 | 330003875 | 1.8 | 53.8 | Palliative (P) | 2014-02-03 | 2014-06-30 | R2W trial | 02 | N | 330007645 | TRIAL |
| 330009839 | 330003875 | 1.58 | 65.8 | Curative (C) | 2013-04-15 | 2013-06-30 | Cisplatin | N | N | 330007645 | CISPLATIN |
| 330009840 | 330003877 | 1.09 | 45.5 | Palliative (P) | 2017-12-04 | 2017-12-28 | EW EuroEwing 2012 Arm A VAI | 02 | null | 330007660 | TRIAL |
| 330009842 | 330003880 | 1.66 | 11.5 | Curative (C) | 2014-05-18 | 2014-05-19 | Doxorubicin 75mg/m2 | N | Y | 330007663 | DOXORUBICIN |
| 330009843 | 330003882 | 1.86 | 63.4 | Adjuvant (A) | 2017-07-06 | 2017-09-24 | Cisplatin 7 day | N | N | 330007666 | CISPLATIN |
| 330009844 | 330003883 | 1.58 | 23 | Not known (9) | 2014-09-10 | 2014-11-06 | Cisplatin | 1 | N | 330007672 | CISPLATIN |
| 330009845 | 330008106 | 1.73 | 96.45 | Adjuvant (A) | 2013-11-14 | 2015-09-15 | Mifamurtide weeks 1-12 | 02 | N | 330007676 | MIFAMURTIDE |
| 330009846 | 330003886 | 1.63 | 89 | Palliative (P) | 2018-05-06 | 2018-05-24 | METHOTREXATE | N | N | 330007676 | METHOTREXATE |
| 330009847 | 330013021 | 1.86 | 48.3 | Curative (C) | 2016-07-25 | 2016-12-10 | MIFAMURTIDE | N | N | 330007685 | MIFAMURTIDE |
| 330009848 | 330003888 | 1.64 | null | Curative (C) | 2016-04-18 | 2016-07-17 | Cisplatin | 1 | N | 330007692 | CISPLATIN |
| 330009849 | 330003888 | 1.63 | 62 | Neo-adjuvant (N) | null | 2015-03-16 | Cisplatin | null | null | 330007692 | CISPLATIN |
| 330009850 | 330003893 | null | null | Palliative (P) | 2013-03-19 | 2013-03-19 | METHOTREXATE | 02 | N | 330007719 | METHOTREXATE |
| 330009851 | 330008112 | 1.79 | null | Curative (C) | 2015-08-31 | 2016-04-07 | METHOTREXATE | N | N | 330007719 | METHOTREXATE |
| 330009852 | 330003902 | 1.9 | 89.2 | Adjuvant (A) | 2017-05-04 | 2017-05-04 | CNS Medbl HR Cyclo+Vinc | Y | N | 330007725 | TRIAL |
| 330009853 | 330003903 | 0 | 60.4 | Palliative (P) | 2017-01-21 | 2017-04-09 | Cisplatin | 2 | Y | 330007728 | CISPLATIN |
| 330009854 | 330003904 | 1.68 | null | Curative (C) | 2017-08-01 | 2017-08-07 | Methotrexate Intermed dose (1g/m2) | N | N | 330007730 | METHOTREXATE |
| 330009855 | 330003906 | null | 45.7 | Neo-adjuvant (N) | 2016-01-06 | 2016-02-17 | METHOTREXATE | 02 | N | 330007739 | METHOTREXATE |
| 330009856 | 330012378 | 1.81 | 60.8 | Curative (C) | 2015-03-30 | 2015-06-14 | Cisplatin | N | Y | 330007750 | CISPLATIN |
| 330009857 | 330003908 | null | 60 | Palliative (P) | null | 2016-09-01 | METHOTREXATE | Y | null | 330007754 | METHOTREXATE |
| 330009858 | 330003912 | 0 | null | Neo-adjuvant (N) | 2017-07-25 | 2018-02-28 | MIFAMURTIDE | N | N | 330007774 | MIFAMURTIDE |
| 330009859 | 330008121 | 1.6 | 82.1 | null | 2015-06-15 | 2015-06-15 | DOXORUBICIN | 02 | N | 330007776 | DOXORUBICIN |
| 330009860 | 330010407 | 1.61 | 47.5 | null | 2013-05-25 | 2013-05-25 | OST Mifamurtide | N | null | 330007780 | MIFAMURTIDE |
| 330009861 | 330003916 | 1.68 | null | Neo-adjuvant (N) | 2015-09-20 | 2015-10-03 | MIFAMURTIDE | N | Y | 330007794 | MIFAMURTIDE |
| 330009862 | 330008123 | null | null | Palliative (P) | 2016-11-26 | 2017-04-05 | Trial Unspecified | 2 | N | 330007804 | TRIAL |
| 330009863 | 330011674 | null | null | null | 2016-08-17 | 2017-02-17 | OST Mifamurtide | N | null | 330007831 | MIFAMURTIDE |
| 330009864 | 330003922 | 1.76 | 49.6 | Curative (C) | 2013-10-17 | 2013-11-14 | Cisplatin 7 day | null | null | 330007855 | CISPLATIN |
| 330009865 | 330003923 | 1.63 | null | Neo-adjuvant (N) | 2016-05-17 | 2016-05-26 | Methotrexate Intermed dose (1g/m2) | N | N | 330007871 | METHOTREXATE |
| 330009866 | 330003924 | 1.72 | 78.4 | Palliative (P) | 2017-06-14 | 2017-07-17 | EW EuroEwing 2012 Arm A VAI | 02 | N | 330007879 | TRIAL |
| 330009867 | 330003925 | 1.76 | 60.7 | Palliative (P) | 2017-06-04 | 2017-06-04 | EW EuroEwing 2012 Arm B IE | null | null | 330007888 | TRIAL |
| 330009868 | 330003926 | 1.61 | 16.3 | Palliative (P) | null | 2016-12-09 | DOXORUBICIN | null | null | 330007890 | DOXORUBICIN |
| 330009869 | 330003928 | 1.6 | null | Curative (C) | 2015-03-30 | 2015-04-24 | DOXORUBICIN | null | N | 330007891 | DOXORUBICIN |
| 330009870 | 330003929 | 1.55 | 102.55 | Curative (C) | null | 2016-07-11 | Trial Unspecified | N | null | 330007899 | TRIAL |
| 330009871 | 330003934 | 1.85 | 65.1 | Curative (C) | 2017-11-25 | 2017-11-29 | Cisplatin | 2 | N | 330007924 | CISPLATIN |